These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21351090)
1. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells. Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090 [TBL] [Abstract][Full Text] [Related]
2. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity. Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma. Kohga K; Tatsumi T; Tsunematsu H; Aono S; Shimizu S; Kodama T; Hikita H; Yamamoto M; Oze T; Aketa H; Hosui A; Miyagi T; Ishida H; Hiramatsu N; Kanto T; Hayashi N; Takehara T Cancer Immunol Immunother; 2012 Sep; 61(9):1425-32. PubMed ID: 22302133 [TBL] [Abstract][Full Text] [Related]
4. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521 [TBL] [Abstract][Full Text] [Related]
5. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma. Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237 [TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408 [TBL] [Abstract][Full Text] [Related]
7. Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma. Shin SK; Oh S; Chun SK; Ahn MJ; Lee SM; Kim K; Kang H; Lee J; Shin SP; Lee J; Jung YK J Gastroenterol Hepatol; 2024 Sep; 39(9):1717-1727. PubMed ID: 38800890 [TBL] [Abstract][Full Text] [Related]
8. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Kohga K; Takehara T; Tatsumi T; Ishida H; Miyagi T; Hosui A; Hayashi N Hepatology; 2010 Apr; 51(4):1264-73. PubMed ID: 20099300 [TBL] [Abstract][Full Text] [Related]
11. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785 [TBL] [Abstract][Full Text] [Related]
12. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203 [TBL] [Abstract][Full Text] [Related]
13. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. Shin S; Kim M; Lee SJ; Park KS; Lee CH Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002 [TBL] [Abstract][Full Text] [Related]
14. Concomitant overexpression of heat-shock protein 70 and HLA class-I in hepatitis C virus-related hepatocellular carcinoma. Yoshida S; Hazama S; Tokuno K; Sakamoto K; Takashima M; Tamesa T; Torigoe T; Sato N; Oka M Anticancer Res; 2009 Feb; 29(2):539-44. PubMed ID: 19331200 [TBL] [Abstract][Full Text] [Related]
15. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347 [TBL] [Abstract][Full Text] [Related]
16. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients. Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma. Li JJ; Pan K; Gu MF; Chen MS; Zhao JJ; Wang H; Liang XT; Sun JC; Xia JC Chin J Cancer; 2013 Mar; 32(3):141-8. PubMed ID: 22704489 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy. Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325 [TBL] [Abstract][Full Text] [Related]
19. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma. Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma. Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]